Medical Publication
Professionals

Experts who work with experts

Accelerated publication

Accelerated publication allows organizations to take control of their publication timelines, providing the reliable assurances needed when speed is important to your publication strategy.

Accelerated publication options

Taylor & Francis offers two accelerated publishing options, providing you with the flexibility depending on your needs.

These timelines rely on authors making revisions and returning required paperwork on schedule as per our Terms & Conditions. We can reliably meet the tight turnaround times by putting additional resources into monitoring and administering peer review and production processes.
If further re-review is required, this will reset the timeline, with re-review prioritised as per the chosen track.

Accelerated Publication Plus

  • Final decision within 3-5 weeks

  • Approximately 2 weeks or less for peer review

  • 1 week for author revision

  • Acceptance to online publication: 1-2 weeks with first proofs within 5 working days

Cost per article: £5940 / $7840 / €6700

Accelerated Publication

  • Final decision within 9 weeks

  • Approximately 4 weeks or less for peer review

  • 2 week for author revision

  • Acceptance to online publication: 2-3 weeks with first proofs within 5 working days

Cost per article: £3150 / $4200 / €3570

Due to the costs incurred to meet Accelerated Publication timeframes, Taylor & Francis reserves the right to a partial charge of the Accelerated Publication fee if the author withdraws their paper. Please note that the Accelerated Publication service does not include open access; if authors choose open access, a separate additional fee (Article Publishing Charge – APC) will be applicable and the APC varies dependent on the journal.

Publication options comparison

Table Data
JournalStandard options offeredAccelerated PublicationAccelerated Publication Plus
Biologics: Targets and Therapy
Bioanalysis
Biomarkers
Biomarkers in Medicine
Breast Cancer: Targets and Therapy
BioTechniques
Cancer Investigation
Cancer Management and Research
Clinical, Cosmetic and Investigational Dermatology
Clinical Interventions in Aging
Clinical Epidemiology
Clinical Ophthalmology
ClinicoEconomics and Outcomes Research
CNS Oncology
COPD: Journal of Chronic Obstructive Pulmonary Disease
Colorectal Cancer
Current Eye Research
Current Medical Research & Opinion
Degenerative Neurological and Neuromuscular Disease
Drug Design, Development and Therapy
Drug Development and Industrial Pharmacy
Drug, Healthcare and Patient Safety
Epigenomics
Expert Opinion on Biological Therapy
Expert Opinion on Drug Delivery
Expert Opinion on Drug Discovery
Expert Opinion on Drug Metabolism & Toxicology
Expert Opinion on Drug Safety
Expert Opinion on Emerging Drugs
Expert Opinion on Investigational Drugs
Expert Opinion on Orphan Drugs
Expert Opinion on Pharmacotherapy
Expert Opinion on Therapeutic Patents
Expert Opinion on Therapeutic Targets
Expert Review of Anticancer Therapy
Expert Review of Anti-infective Therapy
Expert Review of Cardiovascular Therapy
Expert Review of Clinical Immunology
Expert Review of Clinical Pharmacology
Expert Review of Endocrinology & Metabolism
Expert Review of Gastroenterology & Hepatology
Expert Review of Hematology
Expert Review of Medical Devices
Expert Review of Molecular Diagnostics
Expert Review of Neurotherapeutics
Expert Review of Ophthalmology
Expert Review of Precision Medicine and Drug Development
Expert Review of Pharmacoeconomics & Outcomes Research
Expert Review of Proteomics
Expert Review of Respiratory Medicine
Expert Review of Vaccines
Future Cardiology
Future Microbiology
Future Medical Chemistry
Future Neurology
Future Oncology
Future Rare Diseases
Future Science OA
Future Virology
Future Endocrinology & Metabolism
Hematology
Hepatic Oncology
HIV/AIDS: Research and Palliative Care
Hospital Practice
Immunotargets and Therapy
Immunotherapy
Immunopharmacology and Immunotoxicology
Infection and Drug Resistance
International Journal of Chronic Obstructive Pulmonary Disease
International Journal of General Medicine
International Journal of Nephrology and Renovascular Disease
International Journal of Neuroscience
International Journal of Women’s Health
Journal of Asthma
Journal of Asthma and Allergy
Journal of Blood Medicine
Journal of Dermatological Treatment
Journal of Drug Targeting
Journal of Hepatocellular Carcinoma
Journal of Medical Economics
Lung Cancer Management
Medical Devices Evidence and Research
Melanoma Management
Nanomedicine
Nanotoxicology
Neurodegenerative Disease Management
Neuropsychiatric Disease and Treatment
Nutrition and Dietary Supplements
Oncotargets and Therapy
Pain Management
Patient Preference and Adherence
Patient Related Outcome Measures
Personalized Medicine
Pharmacogenomics
Postgraduate Medicine
Pharmaceutical Development and Technology
Regenerative Medicine
Research and Reports in Urology
Scandinavian Journal of Gastroenterology
Therapeutic Delivery
Therapeutics and Clinical Risk Management
Video Journal of Biomedicine
Xenobiotica

Ensuring quality

Acceptance of articles in all journals offering Accelerated Publication is driven entirely by editorial considerations and independent peer review, ensuring the highest standards are maintained no matter the route to publication. 

Authors are only charged if their paper is accepted; there is no charge for using the service if the paper is rejected. We reserve the right to a partial charge if the author withdraws their paper.  As a publisher, Taylor & Francis uphold the highest standards of ethical publishing and comply with ICMJE, COPE and GPP-22 guidelines.